A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2015 |
| Author/s |
author: Mario Sznol Paolo Antonio Ascierto F Stephen Hodi Jean-Jacques Grob |
| Publication date | November 4, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |